Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
B12 is a lipotrope, but our injections don't stop there as they can also include: By injecting these lipotropes, we ensure that your body receives the full benefits by bypassing your gastrointestinal tract, where nutrients can be broken down or malabsorbed
water injected slowly down the inside vial wall, not onto the lyophilized cake (which protects the peptide structure)
As the active methyl donor form of B12, it participates directly in the neurotransmitter synthesis pathways that matter most for mood regulation
Vitamins in Animal and Human Nutrition (2nd ed.)
